This tool allows subscribers to track the progress of share prices belonging to all of the key listed animal health companies.
Zoetis' Equitape praziquantel-only wormer for horses will be discontinued from the firm's equine product range in October 2018.
Vanessa Macdonald has become the general manager of Zoetis' business branch in New Zealand.
IDEXX Laboratories has expanded its veterinary cloud portfolio with the addition of a new clinical workflow system.
Australian firm Anatara Lifesciences has addressed its recent share price slump, which it has linked to a development deal with Zoetis.
US pet therapeutics company Kindred Biosciences has become a commercial entity around six years after it was founded.
Zoetis' acquisition of Abaxis has now been cleared under the Hart-Scott-Rodino Antitrust Improvements Act (HSR Act).
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.